000 01495 a2200409 4500
005 20250516235559.0
264 0 _c20141217
008 201412s 0 0 eng d
022 _a1546-170X
024 7 _a10.1038/nm.3652
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOng, S Tiong
245 0 0 _aReply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia.
_h[electronic resource]
260 _bNature medicine
_cOct 2014
300 _a1090-1 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aApoptosis Regulatory Proteins
_xgenetics
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xgenetics
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xgenetics
650 0 4 _aLung Neoplasms
_xgenetics
650 0 4 _aMale
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aPolymorphism, Genetic
_xgenetics
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aSequence Deletion
_xgenetics
700 1 _aChuah, Charles T H
700 1 _aKo, Tun Kiat
700 1 _aHillmer, Axel M
700 1 _aLim, Wan-Teck
773 0 _tNature medicine
_gvol. 20
_gno. 10
_gp. 1090-1
856 4 0 _uhttps://doi.org/10.1038/nm.3652
_zAvailable from publisher's website
999 _c24260088
_d24260088